Annual CFI
$60.49 M
+$85.04 M+346.47%
December 31, 2023
Summary
- As of February 8, 2025, UBX annual cash flow from investing activities is $60.49 million, with the most recent change of +$85.04 million (+346.47%) on December 31, 2023.
- During the last 3 years, UBX annual CFI has risen by +$65.70 million (+1261.58%).
- UBX annual CFI is now -10.98% below its all-time high of $67.95 million, reached on December 31, 2019.
Performance
UBX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$6.51 M
+$1.84 M+39.34%
September 30, 2024
Summary
- As of February 8, 2025, UBX quarterly cash flow from investing activities is $6.51 million, with the most recent change of +$1.84 million (+39.34%) on September 30, 2024.
- Over the past year, UBX quarterly CFI has dropped by -$7.74 million (-54.33%).
- UBX quarterly CFI is now -83.76% below its all-time high of $40.06 million, reached on March 31, 2019.
Performance
UBX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$19.10 M
-$7.74 M-28.84%
September 30, 2024
Summary
- As of February 8, 2025, UBX TTM cash flow from investing activities is $19.10 million, with the most recent change of -$7.74 million (-28.84%) on September 30, 2024.
- Over the past year, UBX TTM CFI has dropped by -$26.09 million (-57.73%).
- UBX TTM CFI is now -73.26% below its all-time high of $71.44 million, reached on September 30, 2019.
Performance
UBX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
UBX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +346.5% | -54.3% | -57.7% |
| 3 y3 years | +1261.6% | +3506.8% | +177.8% |
| 5 y5 years | +183.8% | +3506.8% | +177.8% |
UBX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +346.5% | -69.4% | +118.0% | -68.4% | +177.8% |
| 5 y | 5-year | -11.0% | +346.5% | -69.4% | +118.0% | -71.9% | +177.8% |
| alltime | all time | -11.0% | +170.1% | -83.8% | +107.0% | -73.3% | +117.9% |
Unity Biotechnology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.51 M(+39.3%) | $19.10 M(-28.8%) |
| Jun 2024 | - | $4.67 M(-165.0%) | $26.84 M(-16.2%) |
| Mar 2024 | - | -$7.19 M(-147.6%) | $32.03 M(-47.1%) |
| Dec 2023 | $60.49 M(-346.5%) | $15.11 M(+6.1%) | $60.49 M(+33.9%) |
| Sep 2023 | - | $14.25 M(+44.6%) | $45.19 M(-954.4%) |
| Jun 2023 | - | $9.85 M(-53.7%) | -$5.29 M(-307.4%) |
| Mar 2023 | - | $21.28 M(<-9900.0%) | $2.55 M(-110.4%) |
| Dec 2022 | -$24.55 M(-162.4%) | -$191.00 K(-99.5%) | -$24.55 M(+60.7%) |
| Sep 2022 | - | -$36.23 M(-304.8%) | -$15.28 M(-140.1%) |
| Jun 2022 | - | $17.69 M(-404.2%) | $38.11 M(+96.1%) |
| Mar 2022 | - | -$5.82 M(-164.1%) | $19.43 M(-50.6%) |
| Dec 2021 | $39.31 M(-854.9%) | $9.08 M(-47.1%) | $39.31 M(+151.0%) |
| Sep 2021 | - | $17.15 M(-1852.0%) | $15.66 M(-293.3%) |
| Jun 2021 | - | -$979.00 K(-107.0%) | -$8.10 M(-256.1%) |
| Mar 2021 | - | $14.06 M(-196.5%) | $5.19 M(-199.6%) |
| Dec 2020 | -$5.21 M | -$14.57 M(+120.6%) | -$5.21 M(-206.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$6.61 M(-153.7%) | $4.89 M(-86.6%) |
| Jun 2020 | - | $12.31 M(+235.8%) | $36.58 M(+15.9%) |
| Mar 2020 | - | $3.67 M(-182.0%) | $31.56 M(-53.6%) |
| Dec 2019 | $67.95 M(-194.1%) | -$4.47 M(-117.8%) | $67.95 M(-4.9%) |
| Sep 2019 | - | $25.08 M(+244.3%) | $71.44 M(+29.9%) |
| Jun 2019 | - | $7.28 M(-81.8%) | $54.98 M(-221.9%) |
| Mar 2019 | - | $40.06 M(-4150.6%) | -$45.09 M(-37.5%) |
| Dec 2018 | -$72.21 M(-16.3%) | -$989.00 K(-111.5%) | -$72.21 M(+15.9%) |
| Sep 2018 | - | $8.63 M(-109.3%) | -$62.27 M(+4.4%) |
| Jun 2018 | - | -$92.79 M(-816.7%) | -$59.63 M(+330.5%) |
| Mar 2018 | - | $12.95 M(+44.8%) | -$13.85 M(-84.0%) |
| Dec 2017 | -$86.31 M(+3045.2%) | $8.94 M(-20.7%) | -$86.31 M(-9.4%) |
| Sep 2017 | - | $11.27 M(-124.0%) | -$95.25 M(-10.6%) |
| Jun 2017 | - | -$47.01 M(-21.0%) | -$106.52 M(+79.0%) |
| Mar 2017 | - | -$59.51 M | -$59.51 M |
| Dec 2016 | -$2.74 M | - | - |
FAQ
- What is Unity Biotechnology annual cash flow from investing activities?
- What is the all time high annual CFI for Unity Biotechnology?
- What is Unity Biotechnology annual CFI year-on-year change?
- What is Unity Biotechnology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Unity Biotechnology?
- What is Unity Biotechnology quarterly CFI year-on-year change?
- What is Unity Biotechnology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Unity Biotechnology?
- What is Unity Biotechnology TTM CFI year-on-year change?
What is Unity Biotechnology annual cash flow from investing activities?
The current annual CFI of UBX is $60.49 M
What is the all time high annual CFI for Unity Biotechnology?
Unity Biotechnology all-time high annual cash flow from investing activities is $67.95 M
What is Unity Biotechnology annual CFI year-on-year change?
Over the past year, UBX annual cash flow from investing activities has changed by +$85.04 M (+346.47%)
What is Unity Biotechnology quarterly cash flow from investing activities?
The current quarterly CFI of UBX is $6.51 M
What is the all time high quarterly CFI for Unity Biotechnology?
Unity Biotechnology all-time high quarterly cash flow from investing activities is $40.06 M
What is Unity Biotechnology quarterly CFI year-on-year change?
Over the past year, UBX quarterly cash flow from investing activities has changed by -$7.74 M (-54.33%)
What is Unity Biotechnology TTM cash flow from investing activities?
The current TTM CFI of UBX is $19.10 M
What is the all time high TTM CFI for Unity Biotechnology?
Unity Biotechnology all-time high TTM cash flow from investing activities is $71.44 M
What is Unity Biotechnology TTM CFI year-on-year change?
Over the past year, UBX TTM cash flow from investing activities has changed by -$26.09 M (-57.73%)